HNMUF yields 2.47% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, HNMUF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of HNMUF + PFE for your $10,000?
Hana Microelectronics Public Company Limited, together with its subsidiaries, provides electronic manufacturing services. The company manufactures chip-on-board and printed circuit board assemblies, integrated circuit assemblies and tests, and liquid crystal on silicon devices. It also manufactures radio frequency identification devices (RFID), MEMS, and high-temperature polysilicon products. In addition, the company offers agent and customer services; and trades in electronic components. It has operations in Malaysia, the United States, Singapore, China, Taiwan, and internationally. The company serves electronic component companies, original equipment manufacturers, and contract manufacturers for printed circuit assemblies and components/integrated circuits for a range of electronic end applications, such as telecommunication, automotive, computer/cloud computing, mobile phone, medical, RFID, industrial applications, consumer electronics, and test and measurement. Hana Microelectronics Public Company Limited was founded in 1978 and is headquartered in Bangkok, Thailand.
Full HNMUF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.